Design and development of novel N ‐(4‐aminobenzoyl)‐ <scp>l</scp> ‐glutamic acid conjugated 1,3,5‐triazine derivatives as Pf ‐DHFR inhibitor: An in‐silico and in‐vitro study-Reference-Cited by-同舟云学术

Design and development of novel N ‐(4‐aminobenzoyl)‐ l ‐glutamic acid conjugated 1,3,5‐triazine derivatives as Pf ‐DHFR inhibitor: An in‐silico and in‐vitro study

Published:2022-12-21 Issue:4 Volume:37 Page:
ISSN:1095-6670
Container-title:Journal of Biochemical and Molecular Toxicology
language:en
Short-container-title:J Biochem & Molecular Tox

Author:

Adhikari Nayana¹,Choudhury Ayesha A. K.¹,Shakya Anshul¹,Ghosh Surajit K.¹,Patgiri Saurav J.²,Singh Udaya P.³^ORCID,Bhat Hans R.¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences Dibrugarh University Dibrugarh Assam India

2. Regional Medical Research Centre, Indian Council of Medical Research (ICMR) Dibrugarh Assam India

3. Drug Design & Discovery Laboratory, Department of Pharmaceutical Sciences Sam Higginbottom University of Agriculture, Technology & Sciences Prayagraj Uttar Pradesh India

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Toxicology,Molecular Biology,Molecular Medicine,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbt.23290

Reference30 articles.

1. Drug-resistant malaria

2. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase

3. World Malaria Report2020.https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2020

4. World malaria report2019.https://www.who.int/publications/i/item/9789241565721

5. The public health impact of chloroquine resistance in Africa

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent biological applications of heterocyclic hybrids containing s-triazine scaffold;RSC Advances;2023